This webinar will be hosted live and available on-demand

Monday, October 23, 2023 
11:00 AM Eastern Time (5:00 PM CET)

Scientists often use classical immunization strategies and hybridoma technologies to generate antibodies. However, when producing antibodies against poorly immunogenic targets, such as membrane proteins with short extracellular domains, these approaches achieve limited antibody diversity, making it difficult for scientists to select good candidates for pharmaceutical development. Innovative approaches that combine RNA immunization and single cell screening provide unique opportunities for researchers to dramatically speed up antibody discovery against such challenging targets. 

In this webinar brought to you by Bruker, François Romagné will present his work using mRNA immunization and single cell screening to obtain large collections of antibodies with molecular and functional diversity against a difficult-to-target G protein-coupled receptor and ion channel.

Topics to be covered 

  • Generating antibodies against difficult targets with mRNA immunization
  • Beacon® single cell screening technology for antibody discovery
François Romagné, PhD

 François Romagné, PhD
 Professor, ImmunoTechnology
 Aix Marseille University
 Scientific Director, MI-mAbs

Sponsored by